A “Pay-for-Delay” agreement is one in which a brand name pharmaceutical company delays a generic competitor from releasing its generic product to the market, by agreeing to pay the generic brand to hold its competing product off the market for a certain period of time. Typically, a brand name drug company challenges the generic drug… Continue Reading